No Data
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
Monday Market Green Like the Irish, But for How Long: Live Stock News
Perspective Therapeutics Starts Dosing New Cohort for Melanoma Tumor Treatment Therapy
Why Bristol-Myers Squibb Company (BMY) Went Down On Thursday?
Express News | CMS: Deals Signed With Manufacturers of 15 Drugs Covered Under Medicare Part D Selected for Second Cycle of Medicare Drug Price Negotiation Program
Bristol-Myers Squibb Says EU Approves Breyanzi for Relapsed, Refractory Follicular Lymphoma
